ISRCTN86625608已完成4 期
Oral bisphosphonate, alendronate, for the treatment of acute Charcot neuroarthropathy in diabetic patients
Tameside Hospital NHS Foundation Trust (UK)0 个研究点目标入组 78 人开始时间: 2010年7月30日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Type 1 or type 2 diabetes
- •2. Aged 18 - 85 years
- •3. Diabetic neuropathy
- •4. Active Charcot arthropathy
排除标准
- •1. Peripheral vascular disease
- •2. Renal failure
- •3. Foot ulceration or celluitis or osteomyelitis
- •4. Previous amputation (more than midfoot)
- •5. Contraindication to study drug
- •6. Oesophageal or gastric problems (achalasia, ulcers)
- •7. Pregnancy
- •8. Breastfeeding
- •9. Risk factors for jaw osteonecrosis
研究者
相似试验
进行中（未招募）
1 期
Oral alendronate for osteoporosis treatment in non-walking children with cerebral palsyosteoporosis treatment in non-walking children with cerebral palsyEUCTR2006-005678-36-FRCHU de Nice
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuriaISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6
进行中（未招募）
1 期
Treatment with Zoledronic acid or Tenofovir Switching in HIV-Infectedlow bone mineral density - HIVMedDRA version: 16.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2013-003359-39-ESFundació Clínic per a la Recerca Biomèdica84
已完成
4 期
Bisphosphonate Therapy with Zoledronic acid or Tenofovir Switching to Improve Low Bone Mineral Density in HIV-Infected Adults: a Strategic, Randomised TrialHIVosteopeniaInflammatory and Immune System - Other inflammatory or immune system disordersMusculoskeletal - OsteoporosisInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12612000776808St Vincents Hospital84
已完成
不适用
Intravenous bisphosphonates in the prevention of osteoporosis associated with strokeStroke and osteoporosisCirculatory SystemISRCTN57438091Cambridge University Hospitals NHS Foundation Trust (UK)30